Image
Blue cells with equations and circuits in the background.
Homepage hero image overlay Homepage hero image overlay mobile

The Synthetic Biology Consortium was formed as a place for researchers and stakeholders interested in the synthetic biology field to interact and share ideas with each other, as well as to facilitate bringing synthetic biology research to NIH.

Image
SBC Poster Image 2
Homepage hero image overlay Homepage hero image overlay mobile

Synthetic Biology Consortium Meeting

The 2021 Synthetic Biology Consortium Meeting is scheduled for November 4-5, 2021 and will be held virtually. To register for this meeting, please click here. 

slider left Previous slider right Next
Homepage hero image overlay mobile bottom

Upcoming Meeting

The 2021 Synthetic Biology Consortium Meeting is scheduled for November 4-5, 2021 and will be held virtually. The Synthetic Biology Consortium meets annually to facilitate important discussions focused on synthetic biology and cultivate a culture of synthetic biology research at the NIH. The 2021 Synthetic Biology Consortium Meeting will build upon what was started at the first annual meeting by continuing to facilitate networking and collaboration among synthetic biology investigators. Attendees can use this meeting to collaborate with each other on current topics in synthetic biology and engage with NIH program directors. Also, the 2021 meeting will focus on deploying synthetic biology technologies for medical impact by connecting researchers with staff at the FDA to discuss translating synthetic biology research into clinical settings. 

To register, click here. 

Funding Opportunities

Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

Application Due Date:
View More

Notice of Special Interest (NOSI): Administrative Supplement for Providing Travel Support for Awardees to Attend the Annual NIH Synthetic Biology Consortium Meeting (Admin Supp)

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) announces the availability of Administrative Supplements to provide travel support for awardees of the Synthetic Biology for Biomedical Applications Notice (NOT-EB-20-017) to attend the annual NIH Synthetic Biology Consortium Meeting (eligible applicants are those who have received an award made in response to NOT-EB-20-017).

Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

The purpose of this Notice of Special Interest (NOSI) is to announce that the National Center for Complementary and Integrative Health (NCCIH), the National Cancer Institute (NCI), the National Institute of Aging (NIA), the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver Nati

Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

The purpose of this Notice of Special Interest (NOSI) is to announce that the National Center for Complementary and Integrative Health (NCCIH), the National Cancer Institute (NCI), the National Institute of Aging (NIA), the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Eunice Kennedy Shriver Nati

Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) invites applications to develop and apply innovative synthetic biology approaches to address challenges across the spectrum of cancer research. Projects will be required to apply a technology, based on an engineered biological system, to an important and well-defined cancer research question. Collaborative transdisciplinary teams are expected with PIs representing expertise in cancer research, engineering, and other disciplines relevant to synthetic biology.

Agenda 2019

Day 1: October 28, 2019

Time

Session

Room Assignment

8:00am - 8:40am

Registration

 Lower Level Lobby

8:40am - 9:00am

Welcoming Remarks

Bruce Tromberg, NIBIB Institute Director

Synthetic Technologies for Advancement of Research and Therapeutics (START): Topic 016

Current developments in synthetic biology have offered tools to design or modify organisms that can be used for a specific function, allowing for natural biological systems to be tailored as machines that produce desired compounds. Further, synthetic biology has a broad application and can be used to synthesize biologically relevant compounds and therapeutics that are not easily and/or not cost-effectively produced in a traditional laboratory setting.

Synthetic Biology for Engineering Applications (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites applications to conduct research to advance the understanding and application of synthetic biology for human health. It will support 1) the development of innovative tools and technologies in synthetic biology and 2) their application in biomedical research and human health. An integrative research plan based on collaborations of synthetic biologists with computational scientists, cell biologists, engineers, and/or physician scientists is strongly recommended.

Subscribe to